Late-Onset Alzheimer Disease

被引:37
|
作者
Pierce, Aimee L. [1 ,2 ]
Bullain, Szofia S. [3 ,4 ]
Kawas, Claudia H. [5 ,6 ,7 ,8 ]
机构
[1] Univ Calif Irvine, Dept Neurol, 1100 Med Plaza Dr, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1100 Med Plaza Dr, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Dept Neurol, 1515 Hewitt Hall, Irvine, CA 92697 USA
[4] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1515 Hewitt Hall, Irvine, CA 92697 USA
[5] Univ Calif Irvine, Dept Neurol, 1121 Gillespie, Irvine, CA 92697 USA
[6] Univ Calif Irvine, Dept Neurobiol & Behav, 1121 Gillespie, Irvine, CA 92697 USA
[7] Univ Calif Irvine, Dept Epidemiol, 1121 Gillespie, Irvine, CA 92697 USA
[8] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1121 Gillespie, Irvine, CA 92697 USA
基金
美国国家卫生研究院;
关键词
Late-onset; Alzheimer disease; Dementia; Oldest-old; Pathology; OLDEST-OLD; DEMENTIA; ASSOCIATION; AGE; PREDICTORS; EFFICACY; COMMON; RISK;
D O I
10.1016/j.ncl.2017.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The oldest-old represent the fastest growing segment of society, and the risk of developing dementia continues to increase with advancing age into the 9th and 10th decades of life. The most common form of dementia in the oldest-old is Alzheimer disease (AD), although there are often mixed pathologies contributing to dementia in addition to amyloid plaques and neurofibrillary tangles. Diagnosing AD in the oldest-old is challenging due to cognitive and physical changes associated with aging. Treatment remains supportive, with current approved medications able to provide modest symptomatic benefit but unable to slow the progression of disease.
引用
收藏
页码:283 / +
页数:13
相关论文
共 50 条
  • [21] LRP gene and late-onset Alzheimer's disease
    Woodward, R
    Singleton, AB
    Gibson, AM
    Edwardson, JA
    Morris, CM
    LANCET, 1998, 352 (9123): : 239 - 240
  • [22] Early-onset Alzheimer disease in families with late-onset Alzheimer disease - A potential important subtype of familial Alzheimer disease
    Brickell, Kiri L.
    Steinbart, Ellen J.
    Rumbaugh, Malia
    Payami, Haydeh
    Schellenberg, Gerard D.
    Van Deerlin, Vivianna
    Yuan, Wuxing
    Bird, Thomas D.
    ARCHIVES OF NEUROLOGY, 2006, 63 (09) : 1307 - 1311
  • [23] Alzheimer's disease murine models: focus on late-onset disease
    Potenza, M. A.
    Nacci, C.
    Carratu, M. R.
    DRUGS OF THE FUTURE, 2020, 45 (02) : 109 - 117
  • [24] The unsolved relationship of brain aging and late-onset Alzheimer disease
    Kern, Andreas
    Behl, Christian
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10): : 1124 - 1132
  • [25] Plasma cholesterol and risk for late-onset Alzheimer's disease
    Cedazo-Minguez, Angel
    Ismail, Muhammad-Al-Mustafa
    Mateos, Laura
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 495 - 498
  • [26] Search for late-onset familial Alzheimer's disease genes
    Schellenberg, GD
    Yu, CE
    Steinbart, EJ
    Bird, TD
    Wijsman, EM
    Daw, EW
    Payami, H
    Conlon, EM
    Nochlin, D
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S10 - S10
  • [27] The 'eye test' in recognition of late-onset Alzheimer's disease
    Caputo, L
    Casartelli, M
    Perrone, C
    Santori, M
    Annoni, G
    Vergani, C
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1998, 27 (02) : 171 - 177
  • [28] APOE polymorphisms and late-onset Alzheimer disease -: The importance of ethnicity
    Kukull, WA
    Martin, GM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (10): : 788 - 789
  • [29] α2-macroglobulin in late-onset Alzheimer's disease
    Kovacs, DM
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 473 - 479
  • [30] Neuropathology of preclinical and clinical late-onset Alzheimer's disease
    Troncoso, JC
    Cataldo, AM
    Nixon, RA
    Barnett, JL
    Lee, MK
    Checler, F
    Fowler, DR
    Smialek, JE
    Crain, B
    Martin, LJ
    Kawas, CH
    ANNALS OF NEUROLOGY, 1998, 43 (05) : 673 - 676